Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-09T07:17:38.227Z Has data issue: false hasContentIssue false
  • English
  • Français

The Neuroleptic Malignant Syndrome and Pneumomediastinum

Published online by Cambridge University Press:  02 January 2018

Benjamin Hugh Green
Benjamin Hugh Green*
Affiliation:
Professional Unit, Royal Liverpool Hospital, Liverpool
Get access Rights & Permissions [Opens in a new window]

Abstract

A patient is described who suffered from the neuroleptic malignant syndrome, complicated by a pneumomediastinum. This has not been reported previously.

Type
Brief Reports
Information
The British Journal of Psychiatry , Volume 154 , Issue 4 , April 1989 , pp. 560 - 561
Copyright
Copyright © Royal College of Psychiatrists, 1989 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abbott, R. J. & Loizou, L. A. (1986) Neuroleptic malignant syndrome. British Journal of Psychiatry, 148, 47–51.CrossRefGoogle ScholarPubMed
Addonizio, G., Susman, V. L. & Roth, S. D. (1986) Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients. American Journal of Psychiatry, 143, 1587–1590.Google ScholarPubMed
Addonizio, G., & Susman, V. L. (1987) ECT as a treatment alternative for patients with symptoms of the neuroleptic malignant syndrome. Journal of Clinical Psychiatry, 48, 102–105.Google ScholarPubMed
Caroff, S. N. (1980) The neuroleptic malignant syndrome. Journal of Clinical Psychiatry, 41, 79–83.Google ScholarPubMed
Delay, J. & Deniker, P. (1968) Drug induced extrapyramidal syndromes. Handbook of Clinical Neurology, vol. 6. Diseases of the Basal Ganglia. New York: Elsevier.Google Scholar
Dhib-Jalbut, S., Hesselbrock, R., Mouradian, M. M., et al (1987) Bromocriptine treatment of neuroleptic malignant syndrome. Journal of Clinical Psychiatry, 48, 69–73.Google ScholarPubMed
Lavie, C. J. (1986) Neuroleptic malignant syndrome. An underdiagnosed reaction to neuroleptic agents? Postgraduate Medicine, 80, 171–178.Google ScholarPubMed
Maunder, R. J., Pierson, D. J. & Hudson, L. D. (1984) Subcutaneous and mediastinal emphysema. Pathophysiology, diagnosis, and management. Archives of Internal Medicine, 144, 1447–1453.CrossRefGoogle ScholarPubMed
Smego, R. A. & Durack, D. T. (1982) The neuroleptic malignant syndrome. Archives of Internal Medicine, 142, 1183–1185.CrossRefGoogle ScholarPubMed
Ward, A., Chaffman, M. O. & Sorkin, E. M. (1986) Dantrolene. A review of its pharmacodynamic, and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity. Drugs, 32, 130–168.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.